Global Influenza Drugs and Vaccines Market was valued at USD 5 Billion in 2022 and is projected to reach USD 8 Billion by 2030, growing at a CAGR of 6.0% from 2024 to 2030.
The influenza drugs and vaccines market is experiencing significant growth, driven by increasing awareness and the continuous evolution of influenza strains. In 2023, the global influenza vaccine market was valued at approximately $7.97 billion and is projected to reach $17.77 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.6% during the forecast period.
Several factors contribute to this upward trend:
Rising Incidence of Influenza: Annually, there are an estimated 1 billion cases of seasonal influenza worldwide, with 3-5 million resulting in severe illness. This high prevalence underscores the critical need for effective vaccines and treatments.
Advancements in Vaccine Technology: The development of mRNA-based vaccines has revolutionized the field. For instance, British drugmaker GSK announced positive results from its phase intermediate trial of a seasonal flu vaccine using mRNA technology and reported that it will advance to the final phase of clinical development.
Government Initiatives: Many governments are investing in vaccination programs to mitigate the public health impact of influenza, further propelling market growth.
In my personal experience, the increasing availability of quadrivalent vaccines, which protect against four different flu viruses, has provided broader protection. These vaccines have become more prevalent in recent years, offering enhanced immunity compared to the traditional trivalent vaccines.
However, challenges persist. The constant mutation of influenza viruses necessitates regular updates to vaccine formulations, posing logistical hurdles for manufacturers. Additionally, public skepticism towards vaccination can impede market expansion.
Despite these challenges, the market for influenza drugs and vaccines remains robust. Continuous research and development, coupled with public health initiatives, are expected to drive sustained growth in the coming years.
Get an In-Depth Research Analysis of the Global Influenza Drugs and Vaccines Market Size And Forecast [2025-2032]
Bristol Myers Squibb
AstraZeneca
Eli Lilly
Roche
GlaxoSmithKline
Novartis
Pfizer
Sanofi Pasteur
Bayer
Celgene
Seqirus
Protein Sciences Corporation
Serum Institute of India
Emergent Biosolutions
BioCryst Pharmaceuticals
Alvogen
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Influenza Drugs and Vaccines Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Influenza Drugs and Vaccines Market
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Based on Types the Market is categorized into Below types that held the largest Influenza Drugs and Vaccines market share In 2023.
Influenza Drugs
Influenza Vaccines
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Global, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Influenza Drugs and Vaccines Market Research Analysis
1. Introduction of the Global Influenza Drugs and Vaccines Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Influenza Drugs and Vaccines Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Influenza Drugs and Vaccines Market, By Type
6. Global Influenza Drugs and Vaccines Market, By Application
7. Global Influenza Drugs and Vaccines Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Influenza Drugs and Vaccines Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/